Skip to main content

Schott Nexterion

Premium

Schott Nexterion of Duryea, Pa., last week introduced its Slide E epoxy slide product for covalent probe binding with microarrays. The product uses an active coating chemistry for the immobilization of oligonucleotides. The active layer, over a borosilicate glass, is made up of reactive epoxy groups that form a covalent bond with all the probe’s nucleophilic groups, without requiring UV cross-linking or reduction. An amino modification of the oligonucleotide is only necessary when spotting short oligonucleotides (less than or equal to 25 mers). Nexterion Slide E also enables the spotting of small spots and, consequently, high-density microarrays with regular and reproducible spot morphology. The surface chemistry is stable and remains active even during long spotting runs, the company said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.